Promising results of Providence-sponsored trial published in npj Breast Cancer

July 3, 2023 Earle A. Chiles Research Institute

Share this Article
Facebook
Twitter
LinkedIn

The final outcomes from a Providence Cancer Institute-sponsored phase Ib trial were published in npj Breast Cancer on June 21. The trial evaluated pembrolizumab, an immunotherapy, with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic triple-negative breast cancer. Both regimens achieved predetermined safety and efficacy outcomes. The study, “A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer,” was led by David B. Page, M.D., Providence Cancer Institute. npj Breast Cancer is an open access, multidisciplinary research journal dedicated to publishing leading-edge breast cancer research and treatment.

Read about the trial.

Breast cancer survivor, artist gives back to Providence

Providence Willamette Falls celebrates opening of new cancer center

Local grateful patient seeks spine specialist

After his chronic lower back pain suddenly worsened, a local grateful patient sought spine specialist Dr. M...

Of Bravery, Birth and Beauty

A young mother is tested when she receives a cancer diagnosis during pregnancy.

Most Recent Articles

Does Anchorage Need a Freestanding Emergency Department (FSED)?

Promising results of Providence-sponsored trial published in npj Breast Cancer

Previous Article

Next Article

Most Recent Articles

Learn why a proposed FSED is not right for our community.

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Providence Alaska Medical Center recently launched a new care model designed to enhance patient safety and help address the nationwide nurse shortage.

Using a new minimally invasive procedure, Dr. Rishi Kaushal saved Candy Lugo’s life by quickly removing a blood clot that was preventing her from breathing normally.

Over the last ten years, the center has been committed to providing children and adults with a secure and clean environment to play, learn and connect with neighbors and improve their health.

Providence Saint Joseph Medical Center has named Cindy Mahal, DNP, MS, RN, CNOR, its Chief Administrative Officer.

This milestone is yet another example of the exceptional standards we uphold across our ministries and in Orange County said Brian Helleland, chief executive of Providence Orange County/High Desert.

Throughout Breast Cancer Awareness Month, women are urged to prioritize exams, healthy living and follow-ups.

Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

Providence Holy Cross Medical Center is committed to the health and wellness of the community and will make reasonable efforts to ensure that the community is informed of this service line closure.

Debbie Deccio celebrates 50 years of employment at Providence St. Mary

CA Attorney General Lawsuit

Providence Holy Cross Medical Center is dedicated to providing the best possible outcomes for every patient at every stage of a pancreatic cancer diagnosis.

How leading-edge surgery and a strong spirit helped one woman overcome pancreatic cancer.

A new study approach reflects a deeper understanding of cancer at the molecular level and marks a shift away from one-size-fits-all treatments.

For decades, thermal energy—both heat and cold—has been used to treat atrial fibrillation (afib). A breakthrough ablation technology uses a new type of energy—pulsed electric fields—to offer patients

Keeping your bones strong is a smart goal at any age. But a fracture-proof frame becomes even more important after 50, when weakened bones lead to breaks for one in two women and one in five men.